메뉴 건너뛰기
The Lancet Neurology
Volumn 8, Issue 3, 2009, Pages 221-222
Getting the measure of multiple sclerosis
Author keywords

[No Author keywords available]
Indexed keywords

GADOLINIUM; NATALIZUMAB;
EID: 60049091969     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70022-5     Document Type: Letter
Times cited : (2)
References (7)
  • 1
    • 60049089535 scopus 로고    scopus 로고
    • Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
    • 10.1016/S1474-4422(09)70021-3 published online Feb 9.
    • Havrdova E., Galetta S., Hutchinson M., et al. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol (2009) 10.1016/S1474-4422(09)70021-3 published online Feb 9.
    • (2009) Lancet Neurol
    • Havrdova, E.1    Galetta, S.2    Hutchinson, M.3
  • 2
    • 0036783422 scopus 로고    scopus 로고
    • The multiple sclerosis functional composite: a new clinical outcome measure for multiple sclerosis trials
    • Rudick R.A., Cutter G., and Reingold S. The multiple sclerosis functional composite: a new clinical outcome measure for multiple sclerosis trials. Mult Scler 8 (2002) 359-365
    • (2002) Mult Scler , vol.8 , pp. 359-365
    • Rudick, R.A.1    Cutter, G.2    Reingold, S.3
  • 3
    • 55949096821 scopus 로고    scopus 로고
    • Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale
    • Bakshi R., Neema M., Healy B.C., et al. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol 65 (2008) 1449-1453
    • (2008) Arch Neurol , vol.65 , pp. 1449-1453
    • Bakshi, R.1    Neema, M.2    Healy, B.C.3
  • 4
    • 0034676548 scopus 로고    scopus 로고
    • Relapses and progression of disability in multiple sclerosis
    • Confavreux C., Vukusic S., Moreau T., and Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 343 (2000) 1430-1438
    • (2000) N Engl J Med , vol.343 , pp. 1430-1438
    • Confavreux, C.1    Vukusic, S.2    Moreau, T.3    Adeleine, P.4
  • 5
    • 48349142161 scopus 로고    scopus 로고
    • Magnetic resonance imaging as a surrogate outcome measure for multiple sclerosis relapses
    • Petkau J., Reingold S.C., Held U., et al. Magnetic resonance imaging as a surrogate outcome measure for multiple sclerosis relapses. Mult Scler 14 (2008) 770-778
    • (2008) Mult Scler , vol.14 , pp. 770-778
    • Petkau, J.1    Reingold, S.C.2    Held, U.3
  • 6
    • 39749200152 scopus 로고    scopus 로고
    • Disablity and T2 MRI lesions: a 20 year follow-up of patients with relapse onset of multiple sclerosis
    • Fisniku L.K., Brex P.A., Altmann D.R., et al. Disablity and T2 MRI lesions: a 20 year follow-up of patients with relapse onset of multiple sclerosis. Brain 131 (2008) 808-817
    • (2008) Brain , vol.131 , pp. 808-817
    • Fisniku, L.K.1    Brex, P.A.2    Altmann, D.R.3
  • 7
    • 57149117126 scopus 로고    scopus 로고
    • New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab
    • Hartung P. New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab. Lancet Neurol 8 (2009) 28-30
    • (2009) Lancet Neurol , vol.8 , pp. 28-30
    • Hartung, P.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.